Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

SARS-CoV-2 is a case in point ... protein is a class I fusion glycoprotein analogous to those of other beta-corona and respiratory viruses and represents the primary target for neutralizing ...

Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

During the corona pandemic, the vaccination against SARS-CoV-2 did not offer optimal protection. However, a booster vaccination against the same variant or after another infection creates what is ...

The second possibility is that Covid has now settled into a rut, which will see it become progressively milder until it ultimately becomes akin to the common cold. Chin-Hong says that this would make ...

An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...

A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...

The global spread of the SARS-CoV-2 virus and of the Covid-19 disease caused by it is having a serious impact on the economy and society in spring 2020. The long-term consequences of the coronavirus ...

or corona, appearance gives the virus its name. Structural proteins--N, M and E--move inside the cell, where they help new virions form. A SARS-CoV-2 particle enters a person's nose or mouth and ...